BioSig Technologies, Inc. (NASDAQ:BSGM) Sees Significant Decrease in Short Interest

BioSig Technologies, Inc. (NASDAQ:BSGM – Get Rating) was the recipient of a large drop in short interest in the month of April. As of April 30th, there was short interest totalling 1,920,000 shares, a drop of 6.3% from the April 15th total of 2,050,000 shares. Based on an average daily trading volume, of 393,900 shares, the short-interest ratio is currently 4.9 days.

Analysts Set New Price Targets

Several brokerages have recently issued reports on BSGM. Ascendiant Capital Markets assumed coverage on shares of BioSig Technologies in a research note on Monday, February 13th. They issued a “buy” rating and a $5.00 price objective on the stock. Taglich Brothers reiterated a “speculative buy” rating on shares of BioSig Technologies in a report on Monday, April 10th.

Hedge Funds Weigh In On BioSig Technologies

Institutional investors have recently modified their holdings of the company. Nicolet Advisory Services LLC bought a new position in shares of BioSig Technologies in the first quarter valued at approximately $27,000. FAS Wealth Partners Inc. increased its position in BioSig Technologies by 50.0% during the first quarter. FAS Wealth Partners Inc. now owns 45,000 shares of the company’s stock worth $51,000 after acquiring an additional 15,000 shares during the period. IHT Wealth Management LLC increased its position in BioSig Technologies by 58.7% during the first quarter. IHT Wealth Management LLC now owns 55,450 shares of the company’s stock worth $63,000 after acquiring an additional 20,500 shares during the period. PFG Investments LLC bought a new position in BioSig Technologies during the first quarter worth $75,000. Finally, Jane Street Group LLC bought a new position in BioSig Technologies during the fourth quarter worth $29,000. Institutional investors own 9.06% of the company’s stock.

BioSig Technologies Stock Performance

BSGM stock opened at $1.36 on Wednesday. The firm has a 50 day simple moving average of $1.17 and a 200 day simple moving average of $0.86. BioSig Technologies has a 52 week low of $0.25 and a 52 week high of $1.49.

BioSig Technologies Company Profile

(Get Rating)

BioSig Technologies, Inc is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiographic and intra-cardiac signals. Its product PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intra-cardiac signals for patients undergoing electrophysiology procedures.